Globus Medical Inc (GMED)
51.95
+1.47
(+2.91%)
USD |
NYSE |
May 03, 16:00
51.94
0.00 (0.00%)
After-Hours: 20:00
Globus Medical Research and Development Expense (Quarterly): 52.25M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 52.25M |
| September 30, 2023 | 29.33M |
| June 30, 2023 | 21.35M |
| March 31, 2023 | 21.08M |
| December 31, 2022 | 19.51M |
| September 30, 2022 | 18.70M |
| June 30, 2022 | 17.40M |
| March 31, 2022 | 17.41M |
| December 31, 2021 | 51.02M |
| September 30, 2021 | 15.85M |
| June 30, 2021 | 15.55M |
| March 31, 2021 | 14.92M |
| December 31, 2020 | 15.24M |
| September 30, 2020 | 14.42M |
| June 30, 2020 | 39.46M |
| March 31, 2020 | 15.40M |
| December 31, 2019 | 15.50M |
| September 30, 2019 | 14.51M |
| June 30, 2019 | 15.75M |
| March 31, 2019 | 14.32M |
| December 31, 2018 | 13.76M |
| September 30, 2018 | 15.53M |
| June 30, 2018 | 13.52M |
| March 31, 2018 | 12.69M |
| December 31, 2017 | 11.41M |
| Date | Value |
|---|---|
| September 30, 2017 | 10.89M |
| June 30, 2017 | 10.71M |
| March 31, 2017 | 10.67M |
| December 31, 2016 | 13.64M |
| September 30, 2016 | 10.26M |
| June 30, 2016 | 10.59M |
| March 31, 2016 | 10.03M |
| December 31, 2015 | 9.672M |
| September 30, 2015 | 9.25M |
| June 30, 2015 | 9.081M |
| March 31, 2015 | 8.656M |
| December 31, 2014 | 7.883M |
| September 30, 2014 | 8.146M |
| June 30, 2014 | 7.694M |
| March 31, 2014 | 7.443M |
| December 31, 2013 | 6.418M |
| September 30, 2013 | 6.568M |
| June 30, 2013 | 7.037M |
| March 31, 2013 | 6.847M |
| December 31, 2012 | 7.228M |
| September 30, 2012 | 7.022M |
| June 30, 2012 | 6.94M |
| March 31, 2012 | 6.736M |
| December 31, 2011 | 5.773M |
| September 30, 2011 | 5.916M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
14.42M
Minimum
Sep 2020
52.25M
Maximum
Dec 2023
22.35M
Average
17.40M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 368.00M |
| Glaukos Corp | 30.73M |
| PROCEPT BioRobotics Corp | 13.08M |
| Paragon 28 Inc | 8.102M |
| Alphatec Holdings Inc | 22.28M |